HIV vector challenges gene therapy oversight

被引：1

|

作者：

Fox, JL

机构：

[1] Additional reporting John Hodgson,

来源：

NATURE BIOTECHNOLOGY | 1997年 / 15卷 / 09期

关键词：

D O I：

10.1038/nbt0997-832

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：832 / 832

页数：1

相关论文

共 50 条

[1] HIV vector challenges gene therapy oversight
Jeffrey L Fox
Nature Biotechnology, 1997, 15 : 832 - 832
[2] HIV vector challenges gene therapy oversight
Nat Biotechnol, 9 (832):
[3] Challenges in Vector Purification for Gene Therapy
Mirasol, Feliza
BIOPHARM INTERNATIONAL, 2020, 33 (02) : 22 - 23
[4] Challenges in vector and cell manufacturing for gene therapy
Rizzardi, G-P.
HUMAN GENE THERAPY, 2013, 24 (12) : A16 - A16
[5] Challenges in vector and cell manufacturing in gene therapy
Rizzardi, G. P.
HUMAN GENE THERAPY, 2016, 27 (11) : A23 - A23
[6] Gene therapy trials oversight
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (15): : 1950 - 1950
[7] Current progress and challenges in HIV gene therapy
Chung, Janet
Rossi, John J.
Jung, Ulrike
FUTURE VIROLOGY, 2011, 6 (11) : 1319 - 1328
[8] Opportunities and challenges for vector manufacturing used for gene therapy
Ozturk, Sadettin
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[9] Gene Therapy Oversight: Lessons for Nanobiotechnology
Wolf, Susan M.
Gupta, Rishi
Kohlhepp, Peter
JOURNAL OF LAW MEDICINE & ETHICS, 2009, 37 (04): : 659 - 684
[10] The oversight of gene therapy research.
Spink, J
CANCER GENE THERAPY, 1999, 6 (04) : 389 - 389

← 1 2 3 4 5 →